Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Deepak L Bhatt

Showing results (921-930 of 1,708) with videos related to

Pageof 171
Sort By:
Clinical Chemistry|April 17, 2019
Cardiac and Inflammatory Biomarkers Are Associated with Worsening Renal Outcomes in Patients with Type 2 Diabetes Mellitus: Observations from SAVOR-TIMI 53Thomas A Zelniker, David A Morrow, Ofri Mosenzon, et al.
Clinical Cardiology|June 30, 2012
Quality of care and outcomes among patients with acute myocardial infarction by level of kidney function at admission: report from the get with the guidelines coronary artery disease programSamip Vasaiwala, Christopher P Cannon, Gregg C Fonarow, et al.
Therapeutic Advances in Musculoskeletal Disease|November 9, 2023
Rheumatoid arthritis disease activity and adverse events in patients receiving tofacitinib or tumor necrosis factor inhibitors: a <i>post hoc</i> analysis of ORAL SurveillanceGeorge A Karpouzas, Zoltán Szekanecz, Eva Baecklund, et al.
Journal of the Society for Cardiovascular Angiography & Interventions|February 23, 2026
Right-Sided Extravalvular Damage: An Overlooked Driver of Risk Model Failure in Low-Flow, Low-Gradient Aortic StenosisYash Prakash, Akarsh Sharma, Lakshay Chopra, et al.
Nature Reviews. Cardiology|February 19, 2026
Invasive and medical management approaches to non-acute myocardial ischaemic syndromesNicholas Chiu, Deepak L Bhatt, Raffaele De Caterina, et al.
International Journal of Cardiology|July 2, 2011
Impact of non-steroidal anti-inflammatory drugs (NSAIDs) on cardiovascular outcomes in patients with stable atherothrombosis or multiple risk factorsOlivier Barthélémy, Tobias Limbourg, Jean Philippe Collet, et al.
Circulation|April 20, 2011
Randomized trial of atopaxar in the treatment of patients with coronary artery disease: the lessons from antagonizing the cellular effect of Thrombin–Coronary Artery Disease TrialStephen D Wiviott, Marcus D Flather, Michelle L O'Donoghue, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|February 2, 2022
A novel risk score to identify the need for triple antithrombotic therapy in patients with atrial fibrillation undergoing percutaneous coronary intervention: a post hoc analysis of the RE-DUAL PCI trialBastiaan Zwart, Willem Lambertus Bor, Anne Johanna Wilhelmina Maria de Veer, et al.
European Heart Journal. Acute Cardiovascular Care|March 31, 2017
Pulse pressure in acute coronary syndromes: Comparative prognostic significance with systolic blood pressureNigel S Tan, Bradley Sarak, Keith Aa Fox, et al.
JAMA|January 13, 2006
International prevalence, recognition, and treatment of cardiovascular risk factors in outpatients with atherothrombosisDeepak L Bhatt, P Gabriel Steg, E Magnus Ohman, et al.
Pageof 171

Showing results (921-930 of 1,708) with videos related to

Sort By:
Pageof 171
Clinical Chemistry|April 17, 2019
Cardiac and Inflammatory Biomarkers Are Associated with Worsening Renal Outcomes in Patients with Type 2 Diabetes Mellitus: Observations from SAVOR-TIMI 53Thomas A Zelniker, David A Morrow, Ofri Mosenzon, et al.
Clinical Cardiology|June 30, 2012
Quality of care and outcomes among patients with acute myocardial infarction by level of kidney function at admission: report from the get with the guidelines coronary artery disease programSamip Vasaiwala, Christopher P Cannon, Gregg C Fonarow, et al.
Therapeutic Advances in Musculoskeletal Disease|November 9, 2023
Rheumatoid arthritis disease activity and adverse events in patients receiving tofacitinib or tumor necrosis factor inhibitors: a <i>post hoc</i> analysis of ORAL SurveillanceGeorge A Karpouzas, Zoltán Szekanecz, Eva Baecklund, et al.
Journal of the Society for Cardiovascular Angiography & Interventions|February 23, 2026
Right-Sided Extravalvular Damage: An Overlooked Driver of Risk Model Failure in Low-Flow, Low-Gradient Aortic StenosisYash Prakash, Akarsh Sharma, Lakshay Chopra, et al.
Nature Reviews. Cardiology|February 19, 2026
Invasive and medical management approaches to non-acute myocardial ischaemic syndromesNicholas Chiu, Deepak L Bhatt, Raffaele De Caterina, et al.
International Journal of Cardiology|July 2, 2011
Impact of non-steroidal anti-inflammatory drugs (NSAIDs) on cardiovascular outcomes in patients with stable atherothrombosis or multiple risk factorsOlivier Barthélémy, Tobias Limbourg, Jean Philippe Collet, et al.
Circulation|April 20, 2011
Randomized trial of atopaxar in the treatment of patients with coronary artery disease: the lessons from antagonizing the cellular effect of Thrombin–Coronary Artery Disease TrialStephen D Wiviott, Marcus D Flather, Michelle L O'Donoghue, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|February 2, 2022
A novel risk score to identify the need for triple antithrombotic therapy in patients with atrial fibrillation undergoing percutaneous coronary intervention: a post hoc analysis of the RE-DUAL PCI trialBastiaan Zwart, Willem Lambertus Bor, Anne Johanna Wilhelmina Maria de Veer, et al.
European Heart Journal. Acute Cardiovascular Care|March 31, 2017
Pulse pressure in acute coronary syndromes: Comparative prognostic significance with systolic blood pressureNigel S Tan, Bradley Sarak, Keith Aa Fox, et al.
JAMA|January 13, 2006
International prevalence, recognition, and treatment of cardiovascular risk factors in outpatients with atherothrombosisDeepak L Bhatt, P Gabriel Steg, E Magnus Ohman, et al.
Pageof 171